Financial targets
As a responsible member of the financial community and industry, Novo Nordisk is committed to securing the position of its shareholders by pursuing long-term strategic financial targets.
Operating profit growth per annum: 15%
Operating margin: 25%
Return on invested capital (ROIC): 30%
Cash to earnings ratio as a three year average: 70%
